Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma

Published:2021-01 Issue:1 Volume:73 Page:422-436
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Ahn Joseph C.¹,Teng Pai‐Chi²,Chen Pin‐Jung³,Posadas Edwin²⁴⁵,Tseng Hsian‐Rong³,Lu Shelly C.⁶⁷,Yang Ju Dong⁶⁸⁷

Affiliation:

1. Division of Gastroenterology and Hepatology Mayo Clinic Rochester MN

2. Urologic Oncology Program and Uro‐Oncology Research Laboratories Cedars‐Sinai Medical Center Los Angeles CA United States

3. Department of Molecular and Medical Pharmacology California NanoSystems InstituteCrump Institute for Molecular ImagingUniversity of California, Los Angeles Los Angeles CA

4. Translational Oncology Program Cedars‐Sinai Medical Center Los Angeles CA United States

5. Division of Hematology/Oncology Department of Medicine Cedars‐Sinai Medical Center Los Angeles CA United States

6. Division of Digestive and Liver Diseases Department of Medicine Cedars‐Sinai Medical Center Los Angeles CA

7. Samuel Oschin Comprehensive Cancer Institute Cedars‐Sinai Medical Center Los Angeles CA

8. Comprehensive Transplant Center Cedars‐Sinai Medical Center Los Angeles CA

Funder

Foundation for the National Institutes of Health

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31165

Reference95 articles.

1. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level

2. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

3. Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

4. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

5. Biomarkers for Hepatocellular Carcinoma

Cited by 236 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocellular carcinoma imaging: Exploring traditional techniques and emerging innovations for early intervention;Medicine in Novel Technology and Devices;2024-12

2. HN1-mediated activation of lipogenesis through Akt-SREBP signaling promotes hepatocellular carcinoma cell proliferation and metastasis;Cancer Gene Therapy;2024-09-09

3. Enhanced anti-tumor therapy for hepatocellular carcinoma via sorafenib and KIAA1199-siRNA co-delivery liposomes;Saudi Pharmaceutical Journal;2024-09

4. High-throughput enrichment of portal venous circulating tumor cells for highly sensitive diagnosis of CA19-9-negative pancreatic cancer patients using inertial microfluidics;Biosensors and Bioelectronics;2024-09

5. Transarterial chemoembolization plus radiofrequency ablation: One of the effective interventions for hepatocellular carcinoma;iLIVER;2024-09